Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 6-7, 2006, Pages 527-531

  Metan, Gokhan ^a   Hayran, Mutlu ^b   Hascelik, Gulsen ^b   Uzun, Omrum ^b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ESCHERICHIA COLI; FACTORIAL ANALYSIS; FEMALE; HOSPITAL INFECTION; HUMAN; MALE; MORTALITY; PATIENT SELECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STENOTROPHOMONAS MALTOPHILIA; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS INFECTION; EPIDEMIOLOGIC METHODS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; STENOTROPHOMONAS MALTOPHILIA; TURKEY;

EID: 33746606840     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500452481     Document Type: Article

References (18)

1. Jones, RN and Sader, HS and Beach, ML. (2003) Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains of non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001) Int J Antimicrob Agents, 22, pp. 551-6.
2. Senol, E and DesJardin, J and Stark, PC and Barefoot, L and Snydman, DR. (2002) Attributable mortality of Stenotrophomonas maltophilia bacteraemia Clin Infect Dis, 15;34, pp. 1653-6.
3. Hanes, SD and Demirkan, K and Tolley, E and Boucher, BA and Croce, MA and Wood, GC and Fabian, TC. (2002) Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients Clin Infect Dis, 25, pp. 228-35.
4. Dupont, H and Mentec, H and Sollet, JP and Bleichner, G. (2001) Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia Intensive Care Med, 27, pp. 355-62.
5. Denton, M and Kerr, KG. (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Clin Microbiol Rev, 11, pp. 57-80.
6. Lai, CH and Chi, CY and Chen, HP and Chen, TL and Lai, CJ and Fung, CP and (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteraemia J Microbiol Immunol Infect, 37, pp. 350-8.
7. Wang, WS and Liu, CP and Lee, CM and Huang, FY. (2004) Stenotrophomonas maltophilia bacteraemia in adults: 4 y experience in a medical centre in northern Taiwan J Microbiol Immunol Infect, 37, pp. 359-65.
8. Friedman, ND and Korman, TM and Fairley, CK and Franklin, JC and Spelman, DW. (2002) Bacteraemia due to Stenotrophomonas maltophilia: An analysis of 45 episodes J Infect, 45, pp. 47-53.
9. Micozzi, A and Venditti, M and Monaco, M and Friedrich, A and Taglietti, F and Santilli, S and Martino, P. (2000) Bacteraemia due to Stenotrophomonas maltophilia in patients with hematological malignancies Clin Infect Dis, 31, pp. 705-11.
10. Labarca, JA and Leber, AL and Kern, VL and Territo, MC and Brankovic, LE and Bruckner, DA and Pegues, DA. (2000) Outbreak of Stenotrophomonas maltophilia bacteraemia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis Clin Infect Dis, 30, pp. 195-7.
11. Muder, RR and Harris, AP and Muller, S and Edmond, M and Chow, JW and Papadakis, K and (1996) Bacteraemia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, multicentre study of 91 episodes Clin Infect Dis, 22, pp. 508-12.
12. Apisarnthanarak, A and Mayfield, JL and Garison, T and McLendon, PM and DiPersio, JF and Fraser, VJ and Polish, LB. (2003) Risk factors for Stenotrophomonas maltophilia bacteraemia in oncology patients: A case-control study Infect Control Hosp Epidemiol, 24, pp. 269-74.
13. Garner, JS and Jarvis, WR and Emori, TG and Horan, TC and Hughes, JM. (1988) CDC definitions for nosocomial infections Am J Infect Control, 16, pp. 128-40.
14. Jang, TN and Wang, FD and Wang, LS and Liu, CY and Liu, IM. (1992) Xanthomonas maltophilia bacteraemia: An analysis of 32 cases J Formosan Med Assoc, 91, pp. 1170-6.
15. Victor, MA and Arpi, M and Bruun, B and Jonsson, V and Hansen, MM. (1994) Xanthomonas maltophilia bacteraemia in immunocompromized haematological patients Scand J Infect Dis, 26, pp. 163-70.
16. Sanyal, SC and Mokaddas, EM. (1999) The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen J Chemother, 11, pp. 28-33.
17. Aksaray, S and Dokuzoguz, B and Guvener, E and Yucesoy, M and Yulug, N and Kocagoz, S and (2000) Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in 8 hospitals in Turkey J Antimicrob Chemother, 46, pp. 649.
18. Yucesoy, M and Yulug, N and Kocagoz, S and Unal, S and Cetin, S and Calangu, S. (2000) Antimicrobial resistance of Gram-negative isolates from intensive care units in Turkey: Comparison to previous 3 y J Chemother, 12, pp. 294-8.